The News
Sofinnova Partners, leading investor for the 2nd Half 2007
12/11/2007
For the second time this year and the 9th time during the 10 last semesters, Sofinnova Partners is ranked as the most active French Venture Capital, both in French and European companies.
The 10 first investors still realize 50% of the investments and more
The high concentration of investments in the hands of the ten largest investors remains a reality again for this semester, although this percentage is reduced from 56% to 53%. Regarding the relationship between FCPI and other venture capital funds, we are seeing these first six months of the year to a reduction in the share of FCPI. They represent this semester 6 of the 10 most active funds against 7 the previous six-month period. With € 50.9 million invested this semester, the most active investor is Sofinnova again, who has held that position 9 times over of the last 10 semesters.
The champions of the early-stage
The features of early-stage financing and its importance in the chain of private equity lead us to establish a specific classification for the most active in this segment. The early-stage includes seeds and 1st rounds. This ranking, in terms of number of operations, is increasing compared to the previous six-month period with 130 operations against 126 six months ago. 39 of the 50 funds who made an investment this semester saw at least one transaction in early stage during this semester, or 9 additional funds compared to the previous six-month period. Sofinnova binding on the fund again as the most active with 43 million invested over 24 operations.
Source : Chausson Finances
(http://www.chaussonfinance.com/indicateur/Indicateur_S1_07.pdf)
In 1998, the fast developing French venture capital industry encouraged Chausson Finance to publish a reporting indicator on the sector in order to provide a clear snapshot of the activity.
Twice a year, the Chausson Finance Indicator highlights investments by French venture capital firms, both in French and European companies, featuring the ranking of the most active investors, number of financed companies, largest rounds, etc.
2007
- 04/01/2007
-
08/01/2007
Movetis NV conclut un premier tour de financement de 49 millions d'euros
- 08/01/2007
- 09/01/2007
-
08/01/2007
UPEK is named CES Best of Innovations 2007 Design and Engineering Award Winner
-
16/01/2007
FOVEA Pharmaceuticals SA obtains Exclusive Worldwide Rights on RdCVF Protein Therapy
-
18/01/2007
CoreValve announces the appointment of Dolf Meewis as Vice President of International Sales
-
22/01/2007
INSIDE Launches High Performance MicroPass(R) L4-2G Contactless Platform
- 19/01/2007
-
15/01/2007
Varioptic and Creative Sensor Announce Liquid Lens Mass Production in China
-
24/01/2007
Addex starts Phase IIa Proof of Concept Study on ADX10061 for Smoking Cessation
- 31/01/2007
- 31/01/2007
- 31/01/2007
-
02/02/2007
Lenovo Mobile Selects Esmertec’s Jbed Software Solution to Power Major Platforms for Mobile Handsets
-
28/01/2007
UPEK Delivers First Biometric Security Software Solution for Windows Vista Operating System
- 02/02/2007
-
06/02/2007
Innate Pharma announces operating revenue of 8.4 million euros in 2006 and updates on its finances
-
06/02/2007
CPI Card Group Adopts INSIDE's Next-Generation MicroPass L4-2G Contactless Platform
- 08/02/2007
-
13/02/2007
Discover® Network certifies Inside Contactless chip for contactless payment cards & devices
- 14/02/2007
-
28/02/2007
IDM Pharma Announces the Completion of Enrollment in Two Phase II Trials of Uvidem(R) in Melanoma
- 02/03/2007
-
08/03/2007
7TM Pharma advances the next first-in-class obesity compound into clinical development
- 08/03/2007
-
19/02/2007
Inside Contactless nominated for Performance AWARD Les Echos
-
08/03/2007
Streamezzo expands executive team with general manager for EMEA
- 13/03/2007
- 20/03/2007
- 26/03/2007
- 28/03/2007
- 29/03/2007
- 26/03/2007
-
03/04/2007
EmailVision : Forte progression du Résultat d'Exploitation au 2nd semestre 2006
- 03/04/2007
-
30/03/2007
Inside Extends Smart Card Alliance Involvement Within the Leadership Council
- 05/04/2007
- 10/04/2007
- 10/04/2007
- 17/04/2007
- 17/04/2007
- 08/03/2007
- 20/04/2007
-
20/04/2007
Addex reports positive results in Phase IIa clinical trial with ADX10059 in Migraine
-
26/04/2007
E-Mail Vision Forte croissance de l’activité au 1er trimestre 2007
-
26/04/2007
Innate Pharma S.A. announced two additional clinical trials for its IPH 1101 drug candidate
- 02/05/2007
- 03/05/2007
-
16/05/2007
ReVolt Technology and Phonak AG to Develop Rechargeable Zinc-air Battery Technology for Hearing Aids
- 16/05/2007
- 17/05/2007
-
30/05/2007
Esmertec Announces Robust Operational Performance in Q1 2007
- 05/06/2007
- 04/06/2007
- 01/06/2007
-
06/06/2007
Inside's Micropass reaches new milestone with 20 million units sold
- 07/06/2007
-
06/06/2007
MOVETIS Announces Start of A Phase IIa trial for M0002 in Ascites
- 07/06/2007
-
07/06/2007
NOXXON Pharma announces appointment of Dr. Walter Wenninger as Chairman of the Board
- 12/06/2007
-
23/05/2007
Streamezzo closes its second round of financing with investment from Qualcomm Ventures
- 10/06/2007
- 18/06/2007
-
18/06/2007
Ablynx identifies novel nanobodies® achieving second milestone in Procter & Gamble collaboration
-
21/06/2007
Innate Pharma has received approval for its phase II trial with IPH 1101 in HCV in France
- 21/06/2007
-
25/06/2007
Innate Pharma annonce un nouvel essai clinique avec IPH 2101 (NN 1975), le premier sous U.S ind
- 25/06/2007
- 27/06/2007
- 27/06/2007
-
29/06/2007
Frost & Sullivan Bestows its 2007 global contactless innovation & advancement award
-
02/07/2007
Ablynx announces interim results of first NANOBODY® Phase I study of ALX-0081 (anti-VWF)
- 06/07/2007
-
03/07/2007
Diatos Completes a Series D €9.4 Million Private Financing Round
-
10/07/2007
Sensitive Object and Tyco Electronics' Elo TouchSystems Business Sign License Agreement
- 09/05/2007
- 25/07/2007
-
25/07/2007
Addex Pharmaceuticals : Résultats Financiers du Premier Semestre 2007
-
30/05/2007
CTS International acquires Planet EV product line from Ericsson
- 05/07/2007
- 14/08/2007
- 06/08/2007
- 16/08/2007
- 24/07/2007
- 20/07/2007
-
24/07/2007
CoreValve named to Red Herring magazine’s ‘top 100’ North American private companies
-
22/08/2007
IBM Acquires WebDialogs to Expand Web Conferencing Capabilities in Industry-Leading Lotus Sametime
- 27/08/2007
- 27/08/2007
-
23/08/2007
Software and IT Executives Learn Growth and Exit Strategies at WFS' Fourth Annual London Conference
-
30/08/2007
Stentys appoints Hikmat Hojeibane as Chief Technology Officer
- 06/09/2007
- 07/09/2007
-
17/09/2007
DBV Technologies expands management team and moves to new facilities in Paris
-
18/09/2007
Inside chosen for world's first NFC-enabled M-payment rollout
-
19/09/2007
Sofinnova Partners Names Chika Yoshinaga Vice President, Asia
-
19/09/2007
Sofinnova Partners nomme le Dr Chika Yoshinaga Vice President, en charge de l’Asie
- 24/09/2007
- 24/09/2007
- 25/09/2007
-
25/09/2007
VoluBill raise 10.5 Million Euros to fund aggressive growth strategy
-
25/09/2007
VoluBill lève 10,5 Millions d’Euros pour financer une stratégie de croissance agressive
-
24/09/2007
First-in-man milestone reported for the Stentys bifurcated drug-eluting stent
-
25/09/2007
Purple Labs Raises .5 Million USD in Initial Round of Venture Capital Financing
-
29/09/2007
7TM Pharma hires experienced Director of Business Development and Medical Director
- 24/09/2007
-
01/10/2007
Noxxon Pharma appoints Dr. Joachim Kempeni as Chief Medical Officer
- 04/10/2007
- 10/10/2007
- 19/10/2007
-
22/10/2007
Diatos announces the successful completion of Phase I trial for DTS-201, a novel doxorubicin prodrug
- 23/10/2007
- 24/10/2007
- 23/10/2007
- 30/10/2007
-
30/10/2007
Kyocera WIRELESS and Inside Contactless join forces on NFC integration
- 30/10/2007
- 01/11/2007
-
05/11/2007
Inside Contactless empowers new generation NFC payment project with carrier Far EasTone in Taïwan
- 05/11/2007
- 06/11/2007
-
06/11/2007
ABLYNX RAISES €75 MILLION IN SUCCESSFUL IPO - Largest ever biotech IPO on Euronext Brussels
-
12/11/2007
Sofinnova Partners, leading investor for the 2nd Half 2007
- 23/10/2007
- 23/10/2007
- 07/11/2007
-
09/11/2007
INSIDE Contactless ranked in the Deloitte Technology Fast 50 list for South of France
-
09/11/2007
Noxxon Pharma announces research & development alliance with Roche regarding inflammatory diseases.
- 13/11/2007
- 13/11/2007
-
13/11/2007
DBV Technologies stengthens board of Directors and Scientific Advisory Board
- 13/11/2007
- 14/11/2007
- 15/11/2007
- 05/11/2007
- 12/11/2007
-
16/11/2007
Esmertec reduces debts and increases equity by early conversion of outstanding convertible bonds
-
03/12/2007
Addex and Merck & Co. Collaborate to Develop Drugs for Parkinson’s Disease
- 04/12/2007
-
04/12/2007
Preglem SA announces CHF 36 million Series B funding and new licencing agreement with HRA Pharma
-
27/11/2007
FOVEA Pharmaceuticals Enter Into a Research Collaboration in Ophthalmology With GENZYME Corporation
- 27/11/2007
-
11/12/2007
Nokia Growth Partners leads Series C investment round in INSIDE Contactless
- 12/12/2007
-
13/12/2007
Ascendis Pharma A/S Completes €17.6 Million Series-A Financing
-
16/12/2007
Movistar selects Esmertec’s USSD platform for Latin American operations
-
13/12/2007
Mobile Digital Media Named Exclusive Retail Publisher and Distributor for Atkins™ Carb Counter
-
17/12/2007
Ablynx reports positive phase I results for its anti-thrombotic nanobody®, ALX-0081
- 20/12/2007
-
05/12/2007
SFR adopte la plate-forme de Streamezzo pour optimiser son nouveau portail rich media
-
05/12/2007
SFR adopts Streamezzo's software platform to power new rich media portal
-
10/12/2007
Streamezzo names Alex Middleton General Manager for Americas
- 27/12/2007
- 10/04/2007